GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Restructuring Costs (2009 - 2017)

Updated

Gsk's Restructuring Costs came in at -$205.79 million for the quarter ended Dec 31, 2017, compared with -$295.89 million a year earlier.

Analysis

Gsk (GSK) Restructuring Costs (2009 - 2017) Analysis & Trends

Over the trailing twelve months to Dec 31, 2017, Gsk reported Restructuring Costs of -$1.19 billion.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -205.79 Mn
Dec 31, 2016 1.21 Bn
Sep 30, 2016 198.50 Mn
Jun 30, 2016 336.07 Mn
Mar 31, 2016 269.46 Mn
Dec 31, 2015 2.87 Bn
Mar 31, 2011 -216.19 Mn
Mar 31, 2010 -469.79 Mn
Mar 31, 2009 -379.36 Mn
API Access

Gsk Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=GSK&period=max&api_key=YOUR_API_KEY